Role of Glucagon, Catecholamines, and Growth Hormone in Human Glucose Counterregulation
Open accessThe DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
Abstract
To further characterize mechanisms of glucose counterregulation in man, the effects of pharmacologically inducd deficiencies of glucagon, growth hormone, and catecholamines (alone and in combination) on recovery of plasma glucose from insulin-induced hypoglycemia and attendant changes in isotopically ([3-(3)H]glucose) determined glucose fluxes were studied in 13 normal subjects. In control studies, recovery of plasma glucose from hypoglycemia was primarily due to a compensatory increase in glucose production; the temporal relationship of glucagon, epinephrine, cortisol, and growth hormone responses with the compensatory increase in glucose appearance was compatible with potential participation of all these hormones in acute glucose counterregulation. Infusion of somatostatin (combined deficiency of glucagon and growth hormone) accentuated insulin-induced hypoglycemia (plasma glucose nadir: 36+/-2 ng/dl during infusion of somatostatin vs. 47+/-2 mg/dl in control studies, P < 0.01) and impaired restoration of normoglycemia (plasma glucose at min 90: 73+/-3 mg/dl at end of somatostatin infusion vs. 92+/-3 mg/dl in control studies, P<0.01). This impaired recovery of plasma glucose was due to blunting of the compensatory increase in glucose appearance since glucose disappearance was not augmented, and was attributable to suppression of glucagon secretion rather than growth hormone secretion since these effects of somatostatin were not observed during simultaneous infusion of somatostatin and glucagon whereas infusion of growth hormone along with somatostatin did not prevent the effect of somatostatin. The attenuated recovery of plasma glucose from hypoglycemia observed during somatostatin-induced glucagon deficiency was associated with plasma epinephrine levels twice those observed in control studies. Infusion of phentolamine plus propranolol (combined alpha-and beta-adrenergic blockade) had no effect on plasma glucose or glucose fluxes after insulin administration. However, infusion of somatostatin along with both phentolamine and propranolol further impaired recovery of plasma glucose from hypoglycemia compared to that observed with somatostatin alone (plasma glucose at end of infusions: 52+/-6 mg/dl for somatostatin-phentolamine-propranolol vs. 72+/-5 mg/dl for somatostatin alone, P < 0.01); this was due to further suppression of the compensatory increase in glucose appearance (maximal values: 1.93+/-0.41 mg/kg per min for somatostatin-phentolamine-propranolol vs. 2.86+/-0.32 mg/kg per min for somatostatin alone, P < 0.05). These results indicate that in man (a) restoration of normoglycemia after insulin-induced hypoglycemia is primarily due to a compensatory increase in glucose production; (b) intact glucagon secretion, but not growth hormone secretion, is necessary for normal glucose counterregulation, and (c) adrenergic mechanisms do not normally play an essential role in this process but become critical to recovery from hypoglycemia when glucagon secretion is impaired.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Feinleib, M., & Zar, J. H. (1975) · Journal of the American Statistical Association · doi:10.2307/2285423 · Cited by 12,680
Zar, J. H. (1996) · Cited by 7,837
MURPHY, B. E. P. (1967) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-27-7-973 · Cited by 1,994
Hypoglycemia: A Potent Stimulus to Secretion of Growth Hormone
Roth, J., Glick, S. M., Yalow, R. S., & Berson, S. A. (1963) · Science · doi:10.1126/science.140.3570.987 · Cited by 669
Neural control of the endocrine pancreas.
Woods, S. C., & Porte, D. (1974) · Physiological Reviews · doi:10.1152/physrev.1974.54.3.596 · Cited by 630
ON THE HORMONAL REGULATION OF CARBOHYDRATE METABOLISM; STUDIES WITH C14 GLUCOSE.
DeBodo, R. C., Steele, R., ALTSZULER, N., Dunn, A., & Bishop, J. (1963) · PubMed · Cited by 532
Tissue effects of glucocorticoids
Baxter, J. D., & Forsham, P. H. (1972) · The American Journal of Medicine · doi:10.1016/0002-9343(72)90154-4 · Cited by 503
The Control of Glycogen Metabolism in the Liver
Hers, H. G. (1976) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.45.070176.001123 · Cited by 448
The control of glycogen metabolism in the liver
Hers, H. G., De Wulf, H., & Stalmans, W. (1970) · FEBS Letters · doi:10.1016/0014-5793(70)80569-5 · Cited by 414
Garber, A. J., Cryer, P. E., Santiago, J. V., Haymond, M. W., Pagliara, A. S., & Kipnis, D. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108460 · Cited by 351
Self-citation
Cited by
Items 101–200 of 420
Hypothermia is critical for survival during prolonged insulin-induced hypoglycemia in rats
Buchanan, T. A., Cane, P., Eng, C. C., Sipos, G. F., & Lee, C. T. (1991) · Metabolism · doi:10.1016/0026-0495(91)90118-g · Cited by 55
Glucagon orchestrates stress‐induced hyperglycaemia
Harp, J. B., Yancopoulos, G. D., & Gromada, J. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12668 · Cited by 61
“In non-diabetic individuals; epinephrine stimulates glucagon secretion primarily through β-adrenergic receptors with α-adrenergic receptor stimulation, accounting for no more than 20% of the effect [75].”
BackgroundHypoglycemia induced by excessive rebound secretion of insulin after removal of pheochromocytoma
Akiba, M., Kodama, T., Ito, Y., Obara, T., & Fujimoto, Y. (1990) · World Journal of Surgery · doi:10.1007/bf01658514 · Cited by 55
Plasma glucose and cortisol responses to exogenous insulin in fasted donkeys
Forhead, A. J., & Dobson, H. (1997) · Research in Veterinary Science · doi:10.1016/s0034-5288(97)90202-2 · Cited by 55
Capaldo, B., Santoro, D., Riccardi, G., Perrotti, N., & Saccà, L. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112432 · Cited by 54
Glucose resistance contributes to diabetes mellitus in cirrhosis
Petrides, A. S., Schulze-Berge, D., Vogt, C., Matthews, D. E., & Strohmeye, G. (1993) · Hepatology · doi:10.1002/hep.1840180210 · Cited by 57
Adrenergic control of lipolysis in women compared with men
Schmidt, S. L., Bessesen, D. H., STOTZ, S. A., Peelor, F. F., Miller, B. F., & Horton, T. J. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00003.2014 · Cited by 56
Renal Compensation for Impaired Hepatic Glucose Release During Hypoglycemia in Type 2 Diabetes
Woerle, H. J., Meyer, C., Popa, E. M., Cryer, P. E., & Gerich, J. E. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1386 · Cited by 52
“These hormones act primarily by increasing glucose release and, to a lesser extent, by limiting glucose utilization (4).”
BackgroundSelf-citationGlucose counterregulation during prolonged hypoglycemia in normal humans
Bolli, G. B., Gottesman, I. S., Cryer, P. E., & Gerich, J. E. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.2.e206 · Cited by 52
Self-citationHavel, P. J., Akpan, J. O., Curry, D. L., Stern, J. S., Gingerich, R. L., & Ahren, B. (1993) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1993.265.1.r246 · Cited by 51
Gerich, J. E. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90584-2 · Cited by 50
Self-citationHypoglycemia Counterregulation During Sleep
Gais, S., Born, J., Peters, A., Schultes, B., Heindl, B., Fehm, H. L., & Kern, W. (2003) · Sleep · doi:10.1093/sleep/26.1.55 · Cited by 49
Epifano, L., Vincenzo, A. D., Fanelli, C. G., Porcellati, E., Perriello, G., Feo, P. D., Motolese, M., Brunetti, P., & Bolli, G. B. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf02333019 · Cited by 53
“Blood samples were collected at 5-10 min intervals and were assayed for glucose (Beckman Glucose Analyzer, Beckman Instruments, Fullerton, CA, USA), glucose specific activity [27], insulin 259”
MethodLittle, S. A., Leelarathna, L., Barendse, S. M., Walkinshaw, E., Tan, H. K., Lubina Solomon, A., de Zoysa, N., Rogers, H., Choudhary, P., Amiel, S. A., et al. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2492 · Cited by 48
Cohen, J., VINIK, A. I., Faller, J., & Fox, I. H. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111681 · Cited by 53
Yue, J. T. Y., Riddell, M. C., Burdett, E., Coy, D. H., Efendic, S., & Vranic, M. (2013) · Diabetes · doi:10.2337/db12-1523 · Cited by 45
“17 increase (45), resulting in the consequent inhibition of adrenomedullary epinephrine secretion from the adrenal medulla.”
GPR119 Agonism Increases Glucagon Secretion During Insulin-Induced Hypoglycemia
Li, N. X., Brown, S. N., Kowalski, T. J., Wu, M. S., Yang, L. M., Dai, G., Petrov, A., Ding, Y., Dlugos, T., Wood, H. B., et al. (2018) · Diabetes · doi:10.2337/db18-0031 · Cited by 45
Dietary Energy Partition: The Central Role of Glucose
Remesar, X., & Alemany, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207729 · Cited by 50
Alsahli, M., & Gerich, J. E. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.07.002 · Cited by 53
Self-citationPeacey, S. R. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.5.1458 · Cited by 50
Bolli, G. B., Calabrese, G., Feo, P. D., Compagnucci, P., Zega, G., Angeletti, G., Cartechini, M. G., Santeusanio, F., & Brunetti, P. (1982) · Diabetologia · doi:10.1007/bf00254837 · Cited by 48
“A number of studies have clearly established the primary role of glucagon [ 1 ] and catecholamines [2, 3] and the non-essential role of cortisol and growth hormone [3, 4] in counteracting insulin-induced hypoglycaemia in normal subjects.”
BackgroundHypoglycemia Unawareness—A Review on Pathophysiology and Clinical Implications
Hölzen, L., Schultes, B., Meyhöfer, S. M., & Meyhöfer, S. (2024) · Biomedicines · doi:10.3390/biomedicines12020391 · Cited by 44
“…are more likely to undergo episodes, leading to accidents, injuries, and increased healthcare Disruptions in sleep architecture to hypoglycemic episodes it often goes unnoticed, that healthy individuals to hypoglycemia during hormonal secretion, such as epinephrine, growth hormone sleep.”
BackgroundHepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis
Winnick, J. J., Kraft, G., Gregory, J. M., Edgerton, D. S., Williams, P., Hajizadeh, I. A., Kamal, M. Z., Smith, M., Farmer, B., Scott, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci79895 · Cited by 44
ADRENALINE CAUSES HYPOKALAEMIA IN MAN BY β2 ADRENOCEPTOR STIMULATON
And, A. D. S., & Reid, J. L. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb03436.x · Cited by 41
Hypoglycemia counterregulation in elderly humans: relationship to glucose levels
Ortiz-Alonso, F. J., Galecki, A., Herman, W. H., Smith, M. J., Jacquez, J. A., & Halter, J. B. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.4.e497 · Cited by 43
β-Blockers and Glucose Control
Mills, G. A., & Horn, J. R. (1985) · Annals of Pharmacotherapy · doi:10.1177/106002808501900401 · Cited by 46
CRYER, P. E., WHITE, N. H., & SANTIAGO, J. V. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-2-131 · Cited by 43
Self-citationPrevention and Correction of Hypoglycemia: Relevance to Type 1 Diabetes
Cryer, P. E. (2003) · Type 1 Diabetes · doi:10.1007/978-1-59259-310-1_7 · Cited by 42
Self-citationDiabetes Research in Children Network (DirecNet) Study Group* (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00248.x · Cited by 42
Rosen, S. G., Clutter, W. E., Berk, M. A., Shah, S. D., & Cryer, P. E. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111226 · Cited by 41
Self-citationGrowth hormone enhances the recovery of hypoglycemia via ventromedial hypothalamic neurons
Furigo, I. C., de Souza, G. O., Teixeira, P. D. S., Guadagnini, D., Frazão, R., List, E. O., Kopchick, J. J., Prada, P. O., & Donato, J. (2019) · The FASEB Journal · doi:10.1096/fj.201901315r · Cited by 45
“Thus, via neuroendocrine mechanisms, the counter-regulatory response (CRR) to hypoglycemia robustly increases hepatic glucose production in order to restore bloodglucose levels to a normal range (3, 4).”
BackgroundHorton, T. J., Dow, S., Armstrong, M., & Donahoo, W. T. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90812.2008 · Cited by 49
Glucagon: The effects of its excess and deficiency on insulin action
Fanelli, C. G., Porcellati, F., Rossetti, P., & Bolli, G. B. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.10.018 · Cited by 48
Jackson, P. A., Pagliassotti, M. J., Shiota, M., Neal, D. W., Cardin, S., & Cherrington, A. D. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.6.e1178 · Cited by 41
“INSULIN-INDUCED HYPOGLYCEMIA leads to a counterregulatory response involving the action of a number of hormones (4, 9, 17, 21, 42), neural signals (14, 20, 29, 48, 49, 50, 51), and autoregulatory responses (3, 22, 32, 45) that act in concert to increase glucose production and decrease glucose utilization.”
Backgroundter Braak, E. W. M. T., Appelman, A. M. M. F., van der Tweel, I., Erkelens, D. W., & van Haeften, T. W. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.107 · Cited by 40
“Glucagon release has been identified to play a primary role in the defense against hypoglycemia (11).”
BackgroundBoas, G. R. V., Lemos, J. M. R., de Oliveira, M. W., dos Santos, R. C., da Silveira, A. P. S., Bacha, F. B., Ito, C. N. A., Cornelius, E. B., Lima, F. B., Rodrigues, A. M. S., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227105 · Cited by 52
“However, this counter-regulatory response usually appears only 15 to 20 minutes after insulin injection [77,78].”
BackgroundFlatt, A. J., Peleckis, A. J., Dalton-Bakes, C., Nguyen, H.-L., Ilany, S., Matus, A., Malone, S. K., Goel, N., Jang, S., Weimer, J., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0506 · Cited by 39
“Loss of the glucagon response to hypoglycemia early in type 1 diabetes pathogenesis leads to the reliance on epinephrine to increase EGP (predominantly hepatic) and reduce peripheral glucose utilization required for physiologic glucose counterregulation.(47,48) In long-standing type 1 diabetes the magnitude of the epi…”
Havel, P. J., Parry, S. J., Stern, J. S., Akpan, J. O., Gingerich, R. L., Taborsky, G. J., & CURRY, D. L. (1994) · Metabolism · doi:10.1016/0026-0495(94)90267-4 · Cited by 39
Cryer, P. E., Tse, T. F., Clutter, W. E., & SHAH, S. D. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.2.e198 · Cited by 47
Self-citationEarly posthypoglycemic insulin resistance in man is mainly an effect of beta-adrenergic stimulation.
Attvall, S., Eriksson, B. M., Fowelin, J., von Schenck, H., Lager, I., & Smith, U. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113091 · Cited by 40
Fagerholm, V., Scheinin, M., & Haaparanta‐Solin, M. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.186 · Cited by 40
“Moreover, experimental studies in humans have suggested that adre- nergic counter-regulatory mechanisms become critical only when glucagon secretion is impaired (Rizza et al., 1979; Bolli et al., 1982; Tse et al., 1983; Cryer et al., 1984; Boyle et al., 1989).”
BackgroundContribution of adrenergic mechanisms to glucose counterregulation in humans
De Feo, P., Perriello, G., Torlone, E., Fanelli, C., Ventura, M. M., Santeusanio, F., Brunetti, P., Gerich, J. E., & Bolli, G. B. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.261.6.e725 · Cited by 39
Self-citationRezg, R., Abot, A., Mornagui, B., & Knauf, C. (2018) · Environmental Science and Pollution Research · doi:10.1007/s11356-018-3823-z · Cited by 42
Duseja, A. K., Thumburu, K. K., Das, A., Dhiman, R. K., Chawla, Y. K., Bhadada, S. K., & Bhansali, A. K. (2007) · PubMed · Cited by 44
ÅMAN, J., & WRANNE, L. (1988) · Acta Paediatrica · doi:10.1111/j.1651-2227.1988.tb10698.x · Cited by 37
Smith, S. A., Young, P., & Cawthorne, M. A. (1986) · Biochemical Journal · doi:10.1042/bj2370789 · Cited by 37
Epinephrine Deficiency in Hypocorticotropic Hypopituitary Children*
RUDMAN, D., MOFFITT, S. D., FERNHOFF, P. M., BLACKSTON, R. D., & FARAJ, B. A. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-4-722 · Cited by 37
PHILLIPS, R., Warrell, D. A., Looareesuwan, S., Turner, R. C., Bloom, S. R., Quantrill, D., & Moore, A. R. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91103-7 · Cited by 38
Seminara, S., Merello, G., Masi, S., Filpo, A., Cauza, F. L., D'Onghia, G., Martelli, E., & Loche, S. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00502.x · Cited by 35
Direct muscarinic cholinergic inhibition of hepatic glucose production in humans.
Boyle, P. J., Liggett, S. B., Shah, S. D., & Cryer, P. E. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113617 · Cited by 36
Self-citationThe Effect of Asymptomatic Nocturnal Hypoglycemia on Glycemic Control in Diabetes Mellitus
Perriello, G., Feo, P. D., Torlone, E., Calcinaro, F., Ventura, M. M., Basta, G., Santeusanio, F., Brunetti, P., Gerich, J. E., & Bolli, G. B. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811103191901 · Cited by 40
Self-citationWinter, R. J. (1981) · Metabolism · doi:10.1016/0026-0495(81)90081-0 · Cited by 36
Rat liver responsiveness to gluconeogenic substrates during insulin-induced hypoglycemia
de Souza, H. M., Borba‐Murad, G. R., Ceddia, R. B., Curi, R., Vardanega-Peicher, M., & Bazotte, R. B. (2001) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2001000600012 · Cited by 44
“Braz J Med Biol Res 34(6) 2001 Liver responsiveness to gluconeogenic substrates during hypoglycemia”
BackgroundInfluentialIncreased insulin sensitivity in young, growth hormone deficient children
Husbands, S., Ong, K. K., Gilbert, J., Wass, J. A. H., & Dunger, D. B. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01298.x · Cited by 37
“…ITT stimulus were associated with lower rates of glucose disappearance; thus, GH deficient children showed a Following intravenous insulin administration, blood glucose reaches a nadir after approximately 20 minutes and hormonal counter-regulation only occurs after this time (Rizza et al., 1979).”
BackgroundByrne, W. J., Lippe, B. M., Strobel, C. T., Levin, S. R., Ament, M. E., & Kaplan, S. A. (1981) · Gastroenterology · doi:10.1016/0016-5085(81)90064-0 · Cited by 35
Sparing of Cognitive Function in Mild Hypoglycemia: Dissociation from the Neuroendocrine Response*
Ipp, E., & FORSTER, B. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-4-806 · Cited by 34
BERLIN, I., GRIMALDI, A., LANDAULT, C., ZOGHBI, F., THERVET, F., PUECH, A. J., & LEGRAND, J. C. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-273 · Cited by 32
CORRALL, R. J. M., FRIER, B. M., DAVIDSON, N. M., & FRENCH, E. B. (1981) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1981.tb02117.x · Cited by 33
Gluconeogenesis and hypoglycemia
Frizzell, R. T., Campbell, P. J., & Cherrington, A. D. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040107 · Cited by 35
Hochgeschwender, U., Costa, J. L., Reed, P., Bui, S., & Brennan, M. B. (2003) · Endocrinology · doi:10.1210/en.2003-1008 · Cited by 36
“In humans and mice, insulin-induced hypoglycemia causes rapid increases in plasma glucagon and epinephrine levels at the onset of the glucose counterregulatory response; increases in plasma levels of other hormones, including cortisol, occur later in the counterregulatory process (18, 20, 21).”
BackgroundCLAUSEN‐SJÖBOM, N., Lins, P., Adamson, U., Curstedt, T., & Hamberger, B. (1987) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1987.tb09929.x · Cited by 32
Hypoglycemia and glucose counterregulation in normal and insulin‐dependent diabetic subjects
Amiel, S. A., Tamborlane, W. V., Saccà, L., & Sherwin, R. S. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040108 · Cited by 33
Madsbad, S., Hilsted, J., Krarup, T., Sestoft, L., Christensen, N. J., FABER, O. K., & Tronier, B. (1982) · Diabetologia · doi:10.1007/bf00254298 · Cited by 32
“adrenal ine, g lucagon, cortisol and growth h o r m o n e ) increase in response to insul in - induced h y p o g l y c a e m i a [1, 2].”
BackgroundHypoglycaemia and gastric emptying
Marathe, C. S., Marathe, J. A., Rayner, C. K., Kar, P., Jones, K. L., & Horowitz, M. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13570 · Cited by 32
Transhepatic Glucagon Gradients in Man: Evidence for Glucagon Extraction by Human Liver*
JASPAN, J. B., RUDDICK, J., & RAYFIELD, E. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-2-287 · Cited by 31
Intrauterine growth and postnatal fasting metabolism in infants of obese mothers
Kliegman, R. M., Gross, T. L., Morton, S., et al. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80561-2 · Cited by 31
Selective Counterregulatory Hormone Responses after Oral Glucose in Man*
Kleinbaum, J., & Shamoon, H. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-4-787 · Cited by 31
Role of glucagon in countering hypoglycemia induced by insulin infusion in dogs
Dobbins, R. L., Connolly, C. C., Neal, D. W., Palladino, L. J., Parlow, A. F., & Cherrington, A. D. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.261.6.e773 · Cited by 32
Leibel, R. L., Berry, E. M., & Hirsch, J. (1991) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1991.260.4.r785 · Cited by 38
Oxidative fuel metabolism during mild hypoglycemia: critical role of free fatty acids
Caprio, S., Gelfand, R. A., Tamborlane, W. V., & Sherwin, R. S. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.256.3.e413 · Cited by 30
Exogenous carbohydrate utilisation: Effects on metabolism and exercise performance
Elsayed, M., MacLaren, D. P. M., & Rattu, A. J. M. (1997) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/s0300-9629(97)00064-9 · Cited by 37
Dagogo-Jack, S. (2015) · Diabetes Care · doi:10.2337/dc15-0533 · Cited by 28
Minimizing Morbidity of Hypoglycemia in Diabetes: A Review of Mini-Dose Glucagon
Chung, S. T., & Haymond, M. W. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814547518 · Cited by 31
“In these experiments, replacement glucagon doses of ~7 ng/kg-min resulted in glucagon plasma concentrations of ~40 to 60 pg/ml and relatively small increases in the glucagon infusion rates could result in a rise in blood glucose concentrations.(36,42,55) In addition, we rationalized that since subcutaneous insulin pum…”
BackgroundHypoglycemia in cystic fibrosis: Prevalence, impact and treatment
Moheet, A. A., Chan, C. L., Granados, A., Ode, K. L., Moran, A., & Battezzati, A. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.08.004 · Cited by 30
Affinati, A. H., Wallia, A., & Gianchandani, R. Y. (2021) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-021-00121-y · Cited by 28
“Acute infections also lead to increased insulin resistance through enhanced secretion of the counter-regulatory hormones cortisol, glucagon and growth hormone [13].”
BackgroundEvidence against important catecholamine compensation for absent glucagon counterregulation
De Feo, P., Perriello, G., Torlone, E., Fanelli, C., Ventura, M. M., Santeusanio, F., Brunetti, P., Gerich, J. E., & Bolli, G. B. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.2.e203 · Cited by 28
Self-citationDimitriadis, G. K., Cryer, P., & Gerich, J. E. (1985) · Diabetologia · doi:10.1007/bf00279917 · Cited by 30
Self-citationAdrenergic influence on glucocounterregulation in man
Lilavivat, U., Brodows, R. G., & Campbell, R. G. (1981) · Diabetologia · doi:10.1007/bf00253412 · Cited by 27
“Thus, combined a- and/3-adrenergic blockade during hypoglycaemia could account for increases observed in both epinephrine and norepinephrine [14] levels.”
BackgroundInfluentialCentral Nervous System Control of Nutrient Homeostasis
Woods, S. C., Taborsky, G. J., & Porte, D. (1986) · Comprehensive physiology · doi:10.1002/cphy.cp010407 · Cited by 38
Panzer, J. K., Tamayo, A., & Caicedo, A. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111792 · Cited by 30
Glucagon, Catecholamine, and Symptom Responses to Hypoglycemia in Living Donors of Pancreas Segments
Robertson, R. P., Sutherland, D. E. R., Seaquist, E. R., & Lanz, K. J. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1689 · Cited by 27
Somatostatin Analogues in Diabetes Mellitus
Davies, D. R. R., Turner, S. J., Alberti, K. G. M. M., & Johnston, D. G. (1989) · Diabetic Medicine · doi:10.1111/j.1464-5491.1989.tb02096.x · Cited by 33
Regulation of Carbohydrate Metabolism and Response to Hypoglycemia
Butler, P. C., & Rizza, R. A. (1989) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30386-4 · Cited by 31
Self-citationGray, R. O. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.4.1508 · Cited by 26
Self-citationHoffman, R. P., Sinkey, C. A., Dopp, J. M., & Phillips, B. G. (2002) · Diabetes · doi:10.2337/diabetes.51.3.734 · Cited by 26
“phentolamine (IV PHEN, 500 g/min) (2), intra-arterial propranolol (IA PROP,”
Hypoinsulinemia is not critical to glucose recovery from hypoglycemia in humans
Heller, S. R., & Cryer, P. E. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.261.1.e41 · Cited by 26
Self-citationGlucose in the Control of Glucagon Secretion
Gerich, J. E. (1983) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-69019-8_1 · Cited by 22
Self-citationEffects of catecholamines on secretion of adrenocorticotrophic hormone (ACTH) in man.
Al‐Damluji, S., & REES, L. H. (1987) · Journal of Clinical Pathology · doi:10.1136/jcp.40.9.1098 · Cited by 28
Glycemic Disturbances in Pheochromocytoma and Paraganglioma
Ronen, J. A., Gavin, M., Ruppert, M. D., & Peiris, A. N. (2019) · Cureus · doi:10.7759/cureus.4551 · Cited by 26
Rhyu, Y. A., Jang, J.-Y., Park, S., An, J. H., Kim, D., Kim, S. K., & Song, K. (2019) · Endocrinology and Metabolism · doi:10.3803/enm.2019.34.2.187 · Cited by 25
Decreased hepatic glucagon responses in Type 1 (insulin-dependent) diabetes mellitus
�rskov, L., Alberti, K. G. M. M., Mengel, A., M⊘ller, N., Pedersen, O. B., Rasmussen, O., Seefeldt, T., & Schmitz, O. (1991) · Diabetologia · doi:10.1007/bf00403290 · Cited by 32
“Early studies of counter-regulation in short-term hypoglycaemia [3, 4] and more prolonged hyperinsulinaemia [5] as well as studies using the pituitary-adrenal-pancreatic clamp technique [6, 7] in more prolonged hypoglycaemia have shown that counter-regulation initially mainly involves changes in hepatic glucose produc…”
ResultBinder, C., & Bendtson, I. (1992) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80329-5 · Cited by 31
Decreased plasma epinephrine concentrations after glucose ingestion in humans
Trunet, P. F., Lhoste, F., Ansquer, J.-C., Kestenbaum, S., Sabatier, C., Tillement, J. P., & RAPIN, M. (1984) · Metabolism · doi:10.1016/0026-0495(84)90118-5 · Cited by 24
Effects of Free Fatty Acids, Insulin, Glucagon and Adrenaline on Ketone Body Production in Humans
Miles, J. M., Haymond, M. W., & Gerich, J. E. (1982) · Novartis Foundation symposium · doi:10.1002/9780470720691.ch11 · Cited by 24
Self-citationThe Prevention and Correction of Hypoglycemia
Cryer, P. E. (2001) · Comprehensive Physiology · doi:10.1002/cphy.cp070235 · Cited by 23
Self-citationThe closed‐loop artificial pancreas in 2020
Fabris, C., & Kovatchev, B. P. (2020) · Artificial Organs · doi:10.1111/aor.13704 · Cited by 24
Plasma beta-thromboglobulin response to insulin-induced hypoglycemia in type I diabetic patients
Monnier, L., Lachkar, H., Richard, J.-L., Colette, C., Borgel, D., Orsetti, A., & Mirouze, J. (1984) · Diabetes · doi:10.2337/diab.33.9.907 · Cited by 23
Heller, S. R., & Robinson, R. T. C. E. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00050.x · Cited by 22
Zhou, X., Jhamandas, K. H., & Livett, B. G. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.1.e212 · Cited by 23
Kennedy, F. P., Bolli, G. B., Go, V. L. W., Cryer, P. E., & Gerich, J. E. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-3-602 · Cited by 24
Self-citation
Metadata
- Authors
- Rizza, R. A., Cryer, P. E., & Gerich, J. E.
- Affiliations
- Mayo Clinic (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1979-07-01
- Volume
- 64
- Issue
- 1
- Pages
- 62-71
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC372091
- OpenAlex
- W1600232156
- Semantic Scholar
- 11f4079b84a608bc5984f3e84f9d0ccc73640319
- Cited by
- 421
- References
- 53
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 5 · 2023: 7 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 5 · 2018: 12 · 2017: 2 · 2016: 6 · 2015: 8 · 2014: 5 · 2013: 11 · 2012: 3
- FWCI
- 32.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- glucose counterregulation, insulin-induced hypoglycemia, glucagon, growth hormone, catecholamines, epinephrine, somatostatin, glucose appearance, glucose disappearance, glucose production, cortisol, adrenergic blockade, phentolamine, propranolol, glucose flux, glucagon deficiency, growth hormone deficiency
- MeSH terms
- Adrenergic alpha-Antagonists, Adrenergic beta-Antagonists, Adult, Blood Glucose, Catecholamines, Drug Interactions, Female, Glucagon, Humans, Hypoglycemia, Insulin, Male, Middle Aged, Phentolamine, Propranolol, Somatostatin, Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.